📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Provectus Biopharmaceuticals

1.1 - Company Overview

Provectus Biopharmaceuticals Logo

Provectus Biopharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of investigational therapies for skin, liver, and breast cancers and dermatological conditions, including PV-10, an intratumoral immunotherapy using rose bengal disodium for solid tumors such as melanoma, and PH-10, a topical rose bengal disodium formulation under study.

Products and services

  • Cancer Therapy Development: Cancer-focused programs developing new therapies for the treatment of skin cancer, liver cancer, and breast cancer
  • PH-10: Topical formulation of rose bengal disodium being studied for dermatological conditions by Provectus Biopharmaceuticals in skin-focused research
  • PV-10: Investigational intratumoral immunotherapy using rose bengal disodium for the treatment of solid tumor cancers, including melanoma

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Provectus Biopharmaceuticals

EpiCapture Logo

EpiCapture

HQ: Ireland Website
  • Description: Provider of accurate, non-invasive urine tests to detect aggressive cancers, focused on improving cancer patient care.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EpiCapture company profile →
Northern Biologics Logo

Northern Biologics

HQ: Canada Website
  • Description: Provider of state-of-the-art antibody discovery targeting novel and challenging oncology and fibrosis targets, developing therapeutic antibody candidates derived from a phage display platform developed and refined by world-leading researchers at the University of Toronto.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Northern Biologics company profile →
SonoCiné Logo

SonoCiné

HQ: United States Website
  • Description: Provider of an imaging solution for breast cancer screening, which the company develops and markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SonoCiné company profile →
Agios Logo

Agios

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics focused on cancer metabolism, offering PYRUKYND (mitapivat), an approved therapy for adults with pyruvate kinase deficiency to treat hemolytic anemia; late-stage trials of mitapivat for thalassemia and sickle cell disease; AG-946, an early-stage PK activator; and patient access services including myAgios and a Global Managed Access Program.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Agios company profile →
Adaptimmune Logo

Adaptimmune

HQ: United Kingdom Website
  • Description: Provider of T-cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases, including afami-cel, a single-dose T-cell therapy targeting cancer, and lete-cel, a single-dose T-cell therapy in development for treating solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adaptimmune company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Provectus Biopharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Provectus Biopharmaceuticals

2.2 - Growth funds investing in similar companies to Provectus Biopharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Provectus Biopharmaceuticals

4.2 - Public trading comparable groups for Provectus Biopharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Provectus Biopharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Provectus Biopharmaceuticals

What does Provectus Biopharmaceuticals do?

Provectus Biopharmaceuticals is a provider of investigational therapies for skin, liver, and breast cancers and dermatological conditions, including PV-10, an intratumoral immunotherapy using rose bengal disodium for solid tumors such as melanoma, and PH-10, a topical rose bengal disodium formulation under study.

Who are Provectus Biopharmaceuticals's competitors?

Provectus Biopharmaceuticals's competitors and similar companies include EpiCapture, Northern Biologics, SonoCiné, Agios, and Adaptimmune.

Where is Provectus Biopharmaceuticals headquartered?

Provectus Biopharmaceuticals is headquartered in United States.

How many employees does Provectus Biopharmaceuticals have?

Provectus Biopharmaceuticals has 1,000 employees 🔒.

When was Provectus Biopharmaceuticals founded?

Provectus Biopharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Provectus Biopharmaceuticals in?

Provectus Biopharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Provectus Biopharmaceuticals

Who are the top strategic acquirers in Provectus Biopharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Provectus Biopharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Provectus Biopharmaceuticals?

Top strategic M&A buyers groups and sectors for Provectus Biopharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Provectus Biopharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Provectus Biopharmaceuticals's sector and industry vertical?

Top PE firms investing in Provectus Biopharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Provectus Biopharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Provectus Biopharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Provectus Biopharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Provectus Biopharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Provectus Biopharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Provectus Biopharmaceuticals?

The key public trading comparables and valuation benchmarks for Provectus Biopharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Provectus Biopharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Provectus Biopharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Provectus Biopharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Provectus Biopharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Provectus Biopharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Provectus Biopharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Provectus Biopharmaceuticals